Journal of Biological Chemistry · 2008 · 96 citations · 33 references
Life SciencesInfectious DiseasesMedicinal ChemistryHost-pathogen InteractionsMolecular VirologyVirologyAntiviral PharmacologyHost-virus InteractionsViral EntryViral Hemorrhagic FeversViral InfectionsVirus EntryAntiviral Structure-activity RelationshipsHemorrhagic Viral DiseaseTherapeutic Targeting Of Viral EntryViral Entry InhibitorsViral Entry Mechanisms
Viral hemorrhagic fevers caused by the arenaviruses Lassa virus in Africa and Machupo, Guanarito, Junin, and Sabia virus in South America are among the most devastating emerging human diseases with fatality rates of 15-35% and a limited antiviral therapeutic repertoire available. Here we used high throughput screening of synthetic combinatorial small molecule libraries to identify inhibitors of arenavirus infection using pseudotyped virion particles bearing the glycoproteins (GPs) of highly pathogenic arenaviruses. Our screening efforts resulted in the discovery of a series of novel small molecule inhibitors of viral entry that are highly active against both Old World and New World hemorrhagic arenaviruses. We observed potent inhibition of infection of human and primate cells with live hemorrhagic arenaviruses (IC(50)=500-800 nm). Investigations of the mechanism of action revealed that the candidate compounds efficiently block pH-dependent fusion by the arenavirus GPs (IC(50) of 200-350 nm). Although our lead compounds were potent against phylogenetically distant arenaviruses, they did not show activity against other enveloped viruses with class I viral fusion proteins, indicating specificity for arenavirus GP-mediated membrane fusion.
33
Structure of the Prefusion Form of the Vesicular Stomatitis Virus Glycoprotein G
Stéphane Roche, F.A. Rey, Yves Gaudin et al. · Science · 2007 · 366 citations